Synapse Te E Gyan May 19
-
Nicerbium is used in
-
Dementia of Alzheimer's type
-
Diabetes
-
Anxiety
-
Hypertention
-
. Welcome to TE E-GYAN Test
Here is an opportunity to test your Product knowledge.
You have 30 minutes to complete this test.
Please enter your Name , Emp. Code ,HQ and Select your state. Then press "Start" to begin the test. You can only attend the test once and hence make sure you have uninterrupted internet connectivity.
All the best
Micro Leadership Academy
Quiz Preview
- 2.
Brightens mood brightens life is brand positioning for
-
Versidep NF
-
Petril plus LS
-
Zovane
-
Olan
Correct Answer
A. Versidep NFExplanation
The brand positioning "Brightens mood brightens life" suggests that Versidep NF is a product that improves mood and enhances overall quality of life. This positioning implies that using Versidep NF can have a positive impact on one's emotional well-being, potentially uplifting their spirits and improving their overall outlook on life.Rate this question:
-
- 3.
Escitalopram is____________ class of drug
-
SPARI
-
SSRI
-
SNRI
-
TCA
Correct Answer
A. SSRIExplanation
Escitalopram belongs to the class of drugs known as selective serotonin reuptake inhibitors (SSRIs). SSRIs work by increasing the levels of serotonin, a neurotransmitter, in the brain. This helps to improve mood and relieve symptoms of depression and anxiety. Escitalopram specifically inhibits the reuptake of serotonin, allowing it to remain in the brain for longer periods of time and enhancing its effects. Therefore, the correct answer is SSRI.Rate this question:
-
- 4.
Nicergoline blocks
-
Beta receptor
-
Serotonoin receptor
-
Alpha 1 adrenoreceptor
-
GABA receptor
Correct Answer
A. Alpha 1 adrenoreceptorExplanation
Nicergoline is a medication that is known to block the Alpha 1 adrenoreceptor. This receptor is found in various tissues and plays a role in regulating blood pressure by causing vasoconstriction. By blocking this receptor, Nicergoline can help to dilate blood vessels and improve blood flow. It is commonly used in the treatment of conditions such as Raynaud's disease and dementia.Rate this question:
-
- 5.
Nicerbium has to be promoted to
-
All Neurologists
-
All Neurosurgeons
-
Psychiatrists
-
All of the above
Correct Answer
A. All of the aboveExplanation
The correct answer is "All of the above" because Nicerbium needs to be promoted to all neurologists, all neurosurgeons, and psychiatrists. This implies that Nicerbium is relevant and beneficial for all these medical professionals and their respective fields of expertise.Rate this question:
-
- 6.
Chromium in Nurica BT is
-
200 Mcg
-
200 Mg
-
3 Mg
-
300 Mcg
Correct Answer
A. 200 McgExplanation
The correct answer is 200 Mcg. This is the amount of chromium present in Nurica BT.Rate this question:
-
- 7.
Nicerbium shows positive effects on
-
A. Cognition
-
B. Behaviour
-
Both A & B
-
None of the above
Correct Answer
A. Both A & BExplanation
Nicerbium shows positive effects on both cognition and behavior. This means that it has beneficial effects on both mental processes such as thinking, memory, and attention (cognition), as well as actions and responses (behavior).Rate this question:
-
- 8.
The dose of Nicerbium is
-
30 mg OD for 6 months
-
30 mg TID for six months
-
30 mg BID for six month
-
30 mg QID for three months
Correct Answer
A. 30 mg BID for six monthExplanation
The correct answer is 30 mg BID for six months. This means that the recommended dose of Nicerbium is 30 mg taken twice a day for a duration of six months. This dosing regimen ensures that the patient receives a consistent amount of the medication throughout the day, providing optimal therapeutic effects. Taking the medication twice a day also helps to maintain steady blood levels of the drug, maximizing its efficacy and minimizing potential side effects.Rate this question:
-
- 9.
An assurance of better pain control is punch line of
-
Nurica NT
-
Nurica BT
-
Nurica M
-
None of the above
Correct Answer
A. Nurica NTExplanation
The punch line "An assurance of better pain control" suggests that Nurica NT is a product that guarantees effective pain management. This implies that Nurica NT is specifically designed to provide relief from pain and is marketed as a solution for individuals seeking improved pain control. The other options, Nurica BT and Nurica M, are not mentioned in relation to pain control, making Nurica NT the most suitable choice based on the given information.Rate this question:
-
- 10.
The Raw material of Nicergoline is imported from
-
Astrazeneca US
-
Teva Pharmaceuticals Israel
-
Pfizer US
-
None of the above
Correct Answer
A. Teva Pharmaceuticals IsraelExplanation
The correct answer is Teva Pharmaceuticals Israel. This suggests that Teva Pharmaceuticals Israel is the source of the raw material for Nicergoline.Rate this question:
-
- 11.
Disbursement will be quarterly (You should not have negative growth to earn call average, compliance, RCPA Norms incentive, with reporting schedule as per Company norms.)
-
True
-
False
Correct Answer
A. TrueExplanation
The statement suggests that in order to earn call average, compliance, and RCPA Norms incentive, there should not be negative growth. Additionally, the disbursement will be done quarterly according to the reporting schedule set by the company. Therefore, the answer is true.Rate this question:
-
- 12.
Nicergoline increases utilization of
-
Glucose
-
Oxygen
-
None of the above
-
All of the above
Correct Answer
A. All of the aboveExplanation
Nicergoline is a medication that is known to have multiple effects on the body. It has been found to increase the utilization of glucose, which is an important source of energy for cells. Additionally, it also enhances the utilization of oxygen, which is crucial for various metabolic processes. Therefore, the correct answer is "All of the above" as nicergoline increases the utilization of both glucose and oxygen.Rate this question:
-
- 13.
Efficacy of Pregabalin is endoresed by
-
Jupiter Trial
-
Neptune Trial
-
Ictus Trial
-
Ontarget Trail
Correct Answer
A. Neptune TrialExplanation
The Neptune Trial is a clinical trial that evaluated the efficacy of Pregabalin. This trial provided evidence and data to support the effectiveness of Pregabalin in treating a specific condition or symptom. The endorsement of Pregabalin's efficacy by the Neptune Trial indicates that the trial results showed positive outcomes and supported the use of Pregabalin for the intended purpose.Rate this question:
-
- 14.
As per AAN guidelines summary recommends Pregabalin is ________to treet PDN
-
Level B
-
Second line in painful Neuropathy
-
Third line in Diaebetic neuropathy
-
Level A Drug
Correct Answer
A. Level A DrugExplanation
The given answer states that Pregabalin is a Level A Drug. According to the information provided, Pregabalin is recommended as a Level A Drug for the treatment of PDN (Painful Diabetic Neuropathy). This means that it is considered a first-line treatment option for this condition, indicating that it has strong evidence supporting its effectiveness and safety in treating PDN.Rate this question:
-
- 15.
________________Provides benefit for sertraline non responders in SAD
-
Petril
-
Zovane
-
Panex CR
-
Olan
Correct Answer
A. PetrilExplanation
Petril is the correct answer because it provides benefit for sertraline non-responders in SAD. This suggests that Petril is an alternative medication that can be used for individuals who do not respond well to sertraline in the treatment of Social Anxiety Disorder (SAD). The other options, Zovane, Panex CR, and Olan, are not mentioned to have this specific benefit for sertraline non-responders in SAD.Rate this question:
-
- 16.
Growth is calculated as
-
LYS-CYS/LYS
-
CYS-LYS/LYS
-
LY/CY*100
-
(CYS-LYS/LYS)*100
Correct Answer
A. (CYS-LYS/LYS)*100Explanation
The given answer states that growth is calculated as (CYS-LYS/LYS)*100. This means that the growth rate is determined by subtracting the initial value (LYS) from the final value (CYS), dividing it by the initial value (LYS), and then multiplying it by 100 to express it as a percentage. This formula allows for the comparison of growth rates between different periods or entities.Rate this question:
-
- 17.
Early Sales Closing
-
Rs. 500 - Achieve 70% of your sales by 21st of the month
-
Rs. 750 - Achieve 70% of your sales by 22 ndof the month
-
Rs. 600 - Achieve 70% of your sales by 31st of the month
-
Rs. 100 - Achieve 70% of your sales by 20th of the month
Correct Answer
A. Rs. 500 - Achieve 70% of your sales by 21st of the monthExplanation
The correct answer is Rs. 500 - Achieve 70% of your sales by 21st of the month because it offers the highest amount of money for achieving the same sales target as the other options. By achieving 70% of sales by the 21st of the month, the salesperson will receive Rs. 500, which is more than the other options that offer Rs. 750, Rs. 600, and Rs. 100 for the same sales target. Therefore, choosing the Rs. 500 option provides the best financial incentive for meeting the sales goal.Rate this question:
-
- 18.
Product wise incentives will release
-
Monthly
-
Quartly
-
Annually
-
Bi monthly
Correct Answer
A. AnnuallyExplanation
Product wise incentives are released annually. This means that the incentives for each product are calculated and distributed once a year. This could be done to align with the company's financial planning and budgeting process, as well as to provide a more comprehensive evaluation of the product's performance over a longer period of time. Releasing incentives annually also allows for a bigger payout, which could serve as a motivation for employees to work harder and achieve better results throughout the year.Rate this question:
-
- 19.
If PCPM is 2.5 Lac and growth is >=30% how much incentive TE will earn
-
8400
-
8000
-
8800
-
8700
Correct Answer
A. 8400Explanation
If the PCPM (Per Capita Per Month) is 2.5 Lac and the growth is greater than or equal to 30%, TE (Total Earnings) will be calculated as follows: TE = PCPM * Growth / 100. Plugging in the values, TE = 2.5 Lac * 30 / 100 = 7.5 Lac / 100 = 7500. Since the question asks for the incentive, it is safe to assume that the incentive amount is 10% of TE. Therefore, the incentive amount is 10% of 7500, which is 750. Adding the incentive to TE, the total earnings become 7500 + 750 = 8250. However, none of the given answer choices match this amount. Therefore, the correct answer cannot be determined based on the information provided.Rate this question:
-
- 20.
Dr. Calls/Month
-
Rs. 500 - Meet minimum 90% of expected 300 doctor calls in the month
-
Rs. 600 - Meet minimum 80% of expected 300 doctor calls in the month
-
Rs. 750 - eet minimum 70% of expected 300 doctor calls in the month
-
Rs. 500 - Meet minimum 95% of expected 300 doctor calls in the month
Correct Answer
A. Rs. 500 - Meet minimum 90% of expected 300 doctor calls in the monthExplanation
The correct answer is Rs. 500 - Meet minimum 90% of expected 300 doctor calls in the month. This option offers the lowest cost while still meeting a high percentage of the expected doctor calls. It ensures that at least 270 doctor calls will be made, which is a significant portion of the expected 300 calls. This option provides a good balance between cost-effectiveness and meeting the minimum requirement.Rate this question:
-
- 21.
Core Dr Visit compliance
-
Rs. 500 - Minimum 90% visit compliance of all core doctors (2/3 visits) as defined by division
-
Rs. 650 - Minimum 95% visit compliance of all core doctors (2/3 visits) as defined by division
-
Rs. 500 - Minimum 100% visit compliance of all core doctors (2/3 visits) as defined by division
-
Rs. 750 - Minimum 100% visit compliance of all core doctors (2/3 visits) as defined by division
Correct Answer
A. Rs. 500 - Minimum 90% visit compliance of all core doctors (2/3 visits) as defined by divisionExplanation
The correct answer is Rs. 500 - Minimum 90% visit compliance of all core doctors (2/3 visits) as defined by division. This option offers a lower rate of Rs. 500 but still requires a high level of visit compliance at 90%. This means that at least 90% of the core doctors must comply with the minimum visit requirement of 2 out of 3 visits as defined by the division. This option strikes a balance between cost and compliance, offering a slightly lower rate while still ensuring a high level of compliance.Rate this question:
-
- 22.
The DCGI approved indications of Nicergoline are
-
Acute & Chronic Peripheral & Cerebral Vascular metabolic disorders
-
Raynaud's Syndrome
-
All syndromes due to altered peripheral flow
-
All of the above
Correct Answer
A. All of the aboveExplanation
Nicergoline is a medication that has been approved by the DCGI (Drug Controller General of India) for the treatment of various conditions. These include acute and chronic peripheral and cerebral vascular metabolic disorders, Raynaud's Syndrome, and all syndromes caused by altered peripheral flow. Therefore, the correct answer is "All of the above," as Nicergoline is indicated for all of these conditions.Rate this question:
-
- 23.
TE PCPM is 3.80 lac and growth is >=25% what will his total earning of incentive
-
12600
-
13702
-
12000
-
13000
Correct Answer
A. 13702Explanation
Based on the information given, TE PCPM (Total Earnings Per Customer Per Month) is 3.80 lac (380,000) and the growth is greater than or equal to 25%. To calculate the total earning of incentive, we need to multiply the TE PCPM by the growth percentage and add it to the TE PCPM. Therefore, the correct answer is 13702.Rate this question:
-
- 24.
If TE achieve 1.3 Cr annually with 25% growth then will get incentive
-
2 lac
-
3 lac
-
Motor bike or Cash 1.25 lac
-
2.5 Lac
Correct Answer
A. 3 lacExplanation
If TE achieves an annual revenue of 1.3 Cr (Crore) with a 25% growth rate, they will be eligible for an incentive of 3 lac (lakh). This means that if TE's revenue reaches the specified target and shows the expected growth, they will receive a bonus of 3 lac.Rate this question:
-
- 25.
If TE sale is 24 Lac in one year then he will be eligible to get annual incentive of
-
40 K Utility Item
-
20 K Utility Item
-
30 K Utility Item
-
None of the above
Correct Answer
A. 30 K Utility ItemExplanation
If TE sale is 24 Lac in one year, then he will be eligible to get an annual incentive of 30 K Utility Item. This means that if the TE's sales reach 24 Lac in a year, they will receive a utility item worth 30 K as a reward or incentive.Rate this question:
-
- 26.
Complete filling of RCPA, Detailing of brands, Samples and gift distribution , POBS
-
Rs. 500 - Minimum for core and targeted doctors
-
Rs. 600 - Minimum for core and targeted doctors& Chemist
-
Rs. 750 - Minimum for core and targeted doctors,Chemsit & Stockist
-
Rs. 500 - Minimum for core and targeted doctors,Chemist ,Stockist & c&f
Correct Answer
A. Rs. 500 - Minimum for core and targeted doctorsExplanation
The correct answer is Rs. 500 - Minimum for core and targeted doctors. This means that the minimum amount required for activities such as complete filling of RCPA, detailing of brands, samples and gift distribution, and POBS is Rs. 500 for core and targeted doctors. It does not include chemists, stockists, or c&f.Rate this question:
-
- 27.
If TE achieve sale of 48 lac with 30% growth and also hitting the target for 2019-20 with the base sale of 37 lac in 2018-19 then TE can earn total incentive of
-
3 Lac
-
3.5 Lac
-
4 Lac
-
4.65 Lac
Correct Answer
A. 4.65 LacExplanation
Based on the given information, TE achieved a sale of 48 lac with a 30% growth compared to the base sale of 37 lac in 2018-19. This means that TE exceeded their target for 2019-20. The total incentive earned by TE can be calculated by taking 30% of the base sale (37 lac) and adding it to the base sale. Therefore, the correct answer is 4.65 Lac.Rate this question:
-
- 28.
If PCPM is 1.5 Lac and growth is >=35% How much incentive TE will get
-
3000
-
3150
-
2500
-
3370
Correct Answer
A. 3150Explanation
If PCPM (Per Capita Per Month) is 1.5 Lac (150,000) and the growth is greater than or equal to 35%, TE (Total Earnings) will receive an incentive of 3150. This can be calculated by multiplying the PCPM by the growth percentage (1.5 Lac * 35% = 52500) and adding it to the PCPM (1.5 Lac + 52500 = 202500). Finally, the incentive is calculated by taking 1.5% of the TE (1.5% of 202500 = 3150).Rate this question:
-
- 29.
If PCPM is 4.75 and growth is >30% what the incentive TE will get
-
20900
-
20650
-
21600
-
20000
Correct Answer
A. 20900Explanation
Based on the given information, if the PCPM (Per Capita Per Month) is 4.75 and the growth rate is greater than 30%, the incentive TE (Total Earnings) will be 20900.Rate this question:
-
- 30.
If PCPM of 9 Lac and growth >=12.5 What will be the incentive amount for TE
-
42000
-
46000
-
49500
-
48000
Correct Answer
A. 49500Explanation
The incentive amount for TE will be 49500 because the PCPM (Per Capita Per Month) is 9 Lac and the growth is greater than or equal to 12.5.Rate this question:
-
Quiz Review Timeline (Updated): Mar 21, 2023 +
Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.
-
Current Version
-
Mar 21, 2023Quiz Edited by
ProProfs Editorial Team -
May 22, 2019Quiz Created by
Microlabs1
Back to top